Literature DB >> 8326994

Disseminated cutaneous and vascular invasion by Fusarium moniliforme in a fatal case of acute lymphocytic leukemia.

A G Smith1, C I Bustamante, C Wood.   

Abstract

A 35 year old female patient with acute lymphocytic leukemia developed fusariosis in which dissemination appeared to be limited to cutaneous and vascular invasion. The first evidence of fungemia occurred nearly seven months after initial hospitalization. The fungus was identified as Fusarium sp. and was considered a contaminant. Two weeks later blood cultures were again positive for Fusarium sp. and the patient was placed on amphotericin B and 5-fluorocytosine therapy. The following day developing lesions were noted on her forearms and face; lesions ultimately spread to her trunk, abdomen, and lower extremities. Skin lesion biopsy sections revealed abundant septate and branching hyphae throughout the dermis and within capillaries. Twenty-six days after the initial isolation the patient died. Post-mortem blood cultures gave rise to the same fungus, which was identified as Fusarium moniliforme. Postmortem cultures and stains of spleen, liver, lung, and brain specimens were all negative for fungi. The primary source and portal of entry of the organism remained undetermined.

Entities:  

Mesh:

Year:  1993        PMID: 8326994     DOI: 10.1007/bf01103704

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  21 in total

1.  Toxin from Fusarium moniliforme: Effects on Plants and Animals.

Authors:  R J Cole; J W Kirksey; H G Cutler; B L Doupnik; J C Peckham
Journal:  Science       Date:  1973-03-30       Impact factor: 47.728

2.  Cutaneous infection in man caused by Fusarium moniliforme.

Authors:  M S Collins; M G Rinaldi
Journal:  Sabouraudia       Date:  1977-07

3.  Natural occurrence of Fusarium toxins in feedstuff.

Authors:  C J Mirocha; S V Pathre; B Schauerhamer; C M Christensen
Journal:  Appl Environ Microbiol       Date:  1976-10       Impact factor: 4.792

Review 4.  Disseminated fusarial infection in the immunocompromised host.

Authors:  S E Richardson; R M Bannatyne; R C Summerbell; J Milliken; R Gold; S S Weitzman
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

5.  Causative fungus agent of leucoencephalomalacia in equine animals.

Authors:  B J Wilson; R R Maronpot
Journal:  Vet Rec       Date:  1971-05-08       Impact factor: 2.695

Review 6.  Diagnosis and successful treatment of fusariosis in the compromised host.

Authors:  W G Merz; J E Karp; M Hoagland; M Jett-Goheen; J M Junkins; A F Hood
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

7.  Invasive Fusarium infections in bone marrow transplant recipients.

Authors:  B R Blazar; D D Hurd; D C Snover; J W Alexander; P B McGlave
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

8.  Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma.

Authors:  T E Kiehn; P E Nelson; E M Bernard; F F Edwards; B Koziner; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

9.  Disseminated Fusarium moniliforme infection after allogeneic marrow transplantation.

Authors:  C H June; P G Beatty; H M Shulman; M G Rinaldi
Journal:  South Med J       Date:  1986-04       Impact factor: 0.954

10.  Fusarium as a pathogen. A case report of Fusarium sepsis and review of the literature.

Authors:  K S Veglia; V J Marks
Journal:  J Am Acad Dermatol       Date:  1987-01       Impact factor: 11.527

View more
  2 in total

1.  Fungicidal activity of cecropin A.

Authors:  A J DeLucca; J M Bland; T J Jacks; C Grimm; T E Cleveland; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

2.  The role of occupation and a past history of malaria in the etiology of classic Kaposi's sarcoma: a case-control study in north-east Sardinia.

Authors:  F Cottoni; M V Masala; M Budroni; M Rosella; R Satta; F Locatelli; M A Montesu; R De Marco
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.